Addus HomeCare (NASDAQ:ADUS) Sets New 12-Month Low - Should You Sell?

Key Points

• New 52-week low: Addus HomeCare shares fell to an intraday low of $92.82 and last traded at $93.85, trading well below its 50-day ($104.87) and 200-day ($110.71) moving averages.
• Analyst mix but upbeat target: The stock carries a consensus rating of "Moderate Buy" with a $133.22 average price target, though some firms have recently cut ratings or targets (e.g., Barclays to $102/underweight).
• Insider selling vs. heavy institutional ownership: Company insiders sold 16,610 shares (~$1.77M) over the past three months (insider ownership 4.5%), while institutions own 95.35% of the stock and several funds materially increased their stakes.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $92.82 and last traded at $93.85, with a volume of 245975 shares. The stock had previously closed at $93.65.

Analyst Ratings Changes

Several brokerages recently commented on ADUS. Barclays cut their price target on shares of Addus HomeCare from $112.00 to $102.00 and set an "underweight" rating on the stock in a report on Wednesday, March 25th. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the stock a "buy" rating in a research note on Wednesday, January 7th. Royal Bank Of Canada restated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday, February 25th. Wall Street Zen cut Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 21st. Finally, KeyCorp reiterated an "overweight" rating on shares of Addus HomeCare in a report on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $133.22.

Addus HomeCare Trading Up 0.2%

The stock has a market capitalization of $1.75 billion, a P/E ratio of 18.01, a PEG ratio of 1.30 and a beta of 0.92. The stock's fifty day moving average price is $104.87 and its 200 day moving average price is $110.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.80.

Insiders Place Their Bets

In related news, EVP David W. Tucker sold 704 shares of the business's stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total value of $75,574.40. Following the completion of the sale, the executive vice president owned 10,802 shares in the company, valued at approximately $1,159,594.70. The trade was a 6.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Poff sold 2,041 shares of the stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the completion of the transaction, the executive vice president directly owned 64,512 shares in the company, valued at approximately $6,901,493.76. This trade represents a 3.07% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 16,610 shares of company stock worth $1,768,970. 4.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Capital Research Global Investors lifted its holdings in shares of Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company's stock worth $157,837,000 after buying an additional 268,192 shares during the period. Tributary Capital Management LLC increased its stake in shares of Addus HomeCare by 114.1% during the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company's stock valued at $46,974,000 after buying an additional 212,192 shares during the period. Freestone Grove Partners LP raised its holdings in shares of Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company's stock valued at $14,813,000 after acquiring an additional 135,246 shares in the last quarter. 8 Knots Management LLC bought a new stake in shares of Addus HomeCare in the third quarter valued at about $6,075,000. Finally, Empowered Funds LLC lifted its stake in Addus HomeCare by 186.1% in the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company's stock worth $7,617,000 after acquiring an additional 46,137 shares during the period. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.